Serevent
Friday, July 1st, 2005When the FDA approved a new drug called Serevent (almeterol xinafoate) for the treatment of asthma in 1994, they were unaware of the problems to come. Serevent, manufactured by GlaxoSmithKline, later had its FDA-approved use extended to include treatment of chronic obstructive pulmonary heart disease. Used daily, Serevent controls the symptoms of asthma and is [...]